SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Technology Stocks : PairGain Technologies -- Ignore unavailable to you. Want to Upgrade?


To: bronco2 who wrote (34878)11/23/1999 5:29:00 PM
From: Larry J.  Read Replies (1) | Respond to of 36349
 
Eric, yes, I have the report, and it's not exactly what it seems (a downgrade). The report explains that Unterberg implemented a new rating system and the new one does not have a "long-term buy" rating. Do to the recent run-up in PAIR's share price and an $18 target, they figured that "NEUTRAL" was appropriate.

"With our previous Long-Term Buy rating on Pairgain being eliminated, we are now instituting the newly established rating of Neutral on PairGain. The neutral rating implies a 12-month total return of less than 15%. Since PairGain is very close to our current 12-month price target of $18 per share, we are comfortable with our Neutral rating on the stock."

Larry



To: bronco2 who wrote (34878)11/23/1999 5:36:00 PM
From: Larry J.  Respond to of 36349
 
Dain Rauscher Wessels (George Notter) MAINTAIN STRONG-BUY AGGRESSIVE RATING. 11/23/99 (9:13 am EST)

*We spoke with PairGain management for an update on December-quarter business trends and current progress with Avidia.
*December business should look much like September-period results.
*Management remains very encouraged by Avidia. The business should generate between $2 - $3 million in sales during December, with a ramp in the business expected next year.
*We continue to rate PAIR shares strong Buy-Aggressive based on the strength of the company's Avidia DSLAM story.

OT: Added RTHM (Are they a PAIR customer?), QWST, ALTR, and EGRP today.

Larry